Zapatero, A <br/><br/>
Dose escalation with three-dimensional conformal radiotherapy for prostate cancer. Is more dose really better in high-risk patients treated with androgen deprivation?  [electronic resource] 

 -  Clinical oncology (Royal College of Radiologists (Great Britain))  Oct 2006 
 - 600-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0936-6555 
<br/><br/><label>Standard No.: </label>10.1016/j.clon.2006.06.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Androgen Antagonists--therapeutic use<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Chemotherapy, Adjuvant<br/>Disease-Free Survival<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Neoplasm Staging<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--drug therapy<br/>Radiotherapy Dosage<br/>Radiotherapy, Conformal--adverse effects<br/>Risk Factors<br/>Treatment Outcome